Market Cap 100.32M
Revenue (ttm) 257.53M
Net Income (ttm) -48.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.94%
Debt to Equity Ratio -2.02
Volume 22,400
Avg Vol 366,152
Day's Range N/A - N/A
Shares Out 196.70M
Stochastic %K 18%
Beta -1.01
Analysts Strong Sell
Price Target $1.23

Company Profile

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. The company offers flowers, extracts, concentrates, edibles, pre-rolls, infused blunts, cannabis-infused gummies and chocolates, tinctures, capsules, softgels, and topical products, as well as vaporization devices and cartridges under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira +...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 561 617 9100
Website: jushico.com
Address:
301 Yamato Road, Suite 3250, Boca Raton, United States
Mess0055
Mess0055 May. 12 at 9:24 PM
$JUSHF Still a ways to go it seems, but steps in the right direction carefully being planned out by leadership.
0 · Reply
Sb123321
Sb123321 May. 5 at 8:14 PM
$JUSHF $MSOS. Updated thoughts. I continue to think that there is no other name in the top 10 MSOS names that has more leverage to S3 and markets transitioning to Adult Use than Jushi. Is there some risk to this view particularily AU in VA. Certainly there is, and that will be crystalized on or before May 22nd. Personally, I think odds still favour passage. I would put it at greater than 70%. Other better informed people have indicated likely higher. Regardless failure which would likely be more of a 1yr delay than outright failure would certainly be a negative but not a death blow. Strategically, assuming we get VA passed I expect JUSHI to outpreform over the next 12-18mths. However, I would caution that I can see a scenario where the first wave of money might go to disporportionally to the larger better known names. Regardless I would expect Justhi would preform well over the cycle and potential could also benefit from a preceived take over premium. I guess time will tell.
1 · Reply
abubnic
abubnic Apr. 30 at 7:53 PM
Oops, re-do. I put the wrong chart in there. The DOJ order has scheduled a hearing on recreational-use drug reclassification. The hearing is scheduled to start on June 29 and conclude by July 15th. The cannabis sector continues its move forward. Today's leaders in % gains: $AAWH $JUSHF $CRLBF $IMCC $CURLF
3 · Reply
abubnic
abubnic Apr. 30 at 7:36 PM
The DOJ order has scheduled a hearing on recreational-use drug reclassification. The hearing is scheduled to start on June 29 and conclude by July 15th. The cannabis sector continues its move forward. Today's leaders in % gains: $AAWH $JUSHF $CRLBF $IMCC $CURLF
1 · Reply
Sb123321
Sb123321 Apr. 27 at 8:55 PM
$JUSHF Nice to see a solid day. However, JUSH is still underpreforming for the week. I suspect it is just a function of people reaching for larger better known names. However given their outsized leverage to S3 and transition to adult use markets (VA and soon PA) relative to their market cap they should really outperform over time. When that shift happens is unclear but quite confident the will perform in the top quartile of the names in the sector over the next 6 to 12 months.
0 · Reply
nottoday800
nottoday800 Apr. 25 at 2:24 PM
$JUSHF beyond hellllllllllo
0 · Reply
Sb123321
Sb123321 Apr. 24 at 3:16 PM
$JUSHF given PA and VA are at this point 100% medical markets Jushi must be something like 65-75% medical.
2 · Reply
Rouler98038
Rouler98038 Apr. 24 at 12:08 AM
$JUSHF Rescheduling is a game changer for Jushi Holdings. 280E tax relief alone can dramatically improve cash flow and profitability—without any revenue growth. This is the kind of shift that can re-rate the entire sector.
0 · Reply
Truthshepherd
Truthshepherd Apr. 17 at 3:28 PM
$JUSHF Virginia adult use will start 2027. Jushi very well situated to capitalize on the tailwinds.
0 · Reply
Truthshepherd
Truthshepherd Apr. 6 at 4:07 PM
$JUSHF just refininced debt and has alot of upside potential with operations in VA and PA, potential acquisition candidate after rescheduling IMO. Regardless, tailwinds are picking up.
0 · Reply
Latest News on JUSHF
No data available.
Mess0055
Mess0055 May. 12 at 9:24 PM
$JUSHF Still a ways to go it seems, but steps in the right direction carefully being planned out by leadership.
0 · Reply
Sb123321
Sb123321 May. 5 at 8:14 PM
$JUSHF $MSOS. Updated thoughts. I continue to think that there is no other name in the top 10 MSOS names that has more leverage to S3 and markets transitioning to Adult Use than Jushi. Is there some risk to this view particularily AU in VA. Certainly there is, and that will be crystalized on or before May 22nd. Personally, I think odds still favour passage. I would put it at greater than 70%. Other better informed people have indicated likely higher. Regardless failure which would likely be more of a 1yr delay than outright failure would certainly be a negative but not a death blow. Strategically, assuming we get VA passed I expect JUSHI to outpreform over the next 12-18mths. However, I would caution that I can see a scenario where the first wave of money might go to disporportionally to the larger better known names. Regardless I would expect Justhi would preform well over the cycle and potential could also benefit from a preceived take over premium. I guess time will tell.
1 · Reply
abubnic
abubnic Apr. 30 at 7:53 PM
Oops, re-do. I put the wrong chart in there. The DOJ order has scheduled a hearing on recreational-use drug reclassification. The hearing is scheduled to start on June 29 and conclude by July 15th. The cannabis sector continues its move forward. Today's leaders in % gains: $AAWH $JUSHF $CRLBF $IMCC $CURLF
3 · Reply
abubnic
abubnic Apr. 30 at 7:36 PM
The DOJ order has scheduled a hearing on recreational-use drug reclassification. The hearing is scheduled to start on June 29 and conclude by July 15th. The cannabis sector continues its move forward. Today's leaders in % gains: $AAWH $JUSHF $CRLBF $IMCC $CURLF
1 · Reply
Sb123321
Sb123321 Apr. 27 at 8:55 PM
$JUSHF Nice to see a solid day. However, JUSH is still underpreforming for the week. I suspect it is just a function of people reaching for larger better known names. However given their outsized leverage to S3 and transition to adult use markets (VA and soon PA) relative to their market cap they should really outperform over time. When that shift happens is unclear but quite confident the will perform in the top quartile of the names in the sector over the next 6 to 12 months.
0 · Reply
nottoday800
nottoday800 Apr. 25 at 2:24 PM
$JUSHF beyond hellllllllllo
0 · Reply
Sb123321
Sb123321 Apr. 24 at 3:16 PM
$JUSHF given PA and VA are at this point 100% medical markets Jushi must be something like 65-75% medical.
2 · Reply
Rouler98038
Rouler98038 Apr. 24 at 12:08 AM
$JUSHF Rescheduling is a game changer for Jushi Holdings. 280E tax relief alone can dramatically improve cash flow and profitability—without any revenue growth. This is the kind of shift that can re-rate the entire sector.
0 · Reply
Truthshepherd
Truthshepherd Apr. 17 at 3:28 PM
$JUSHF Virginia adult use will start 2027. Jushi very well situated to capitalize on the tailwinds.
0 · Reply
Truthshepherd
Truthshepherd Apr. 6 at 4:07 PM
$JUSHF just refininced debt and has alot of upside potential with operations in VA and PA, potential acquisition candidate after rescheduling IMO. Regardless, tailwinds are picking up.
0 · Reply
diamondtouch
diamondtouch Mar. 31 at 12:27 AM
1 · Reply
StonkCapital
StonkCapital Mar. 30 at 5:47 PM
$JUSHF "...the White House has accepted requests for meetings to discuss the yet-to-be-published CBD rule with Trent Woloveck of the multi-state cannabis operator Jushi Holdings on Wednesday..."
0 · Reply
mvesk
mvesk Mar. 25 at 3:03 PM
$JUSHF what the news on earnings?
1 · Reply
Sb123321
Sb123321 Mar. 16 at 3:19 PM
$MSOS Seems like the biggest relative winner on the Virginia news should be $JUSHF.
0 · Reply
Stoney83
Stoney83 Jan. 26 at 4:12 AM
$JUSHF just waiting on Virginia and Pennsylvania to flip, and this thing will be a rocket ship.
2 · Reply
Blome
Blome Jan. 6 at 9:30 PM
$TSNDF $VFF $JUSHF $TCNNF $VRNO https://themarijuanaherald.com/2026/01/senate-sara-carter-cannabis/
0 · Reply
Chairman5
Chairman5 Dec. 18 at 9:22 PM
$JUSHF implosion alert
0 · Reply
Sb123321
Sb123321 Dec. 18 at 4:44 PM
$JUSHF I have said this before be it is worth repeating, If we are truly at the transition point to a more favorable environment for cannabis stock, I can't think of anyone better positioned to benefit than $JUSHF. S3 will benefit the whole industry but on a relative basis Jushi has very high degree of leverage to the elimination of 280E. Same goes for SAFER if in fact that gets mention at today's press conference. But most importantly, it is very exposed to the States who are most likely to go Adult Use. Best territory in VA. 18 dispensaries in PA. These represent over 50% of their dispensaries plus they also have momentum in the recently transitioned State of Ohio. Perhaps there are other names that will benefit similar or even more but I have looked and frankly it isn't easy to identify who they might be.
1 · Reply
Mess0055
Mess0055 Dec. 16 at 6:49 PM
$JUSHF we are about due for some fun here.
0 · Reply
AaronX
AaronX Dec. 16 at 6:01 PM
$JUSHF $JUSH.CSE Looking for the breakout above the weekly 200sma, next short term price target is $1.50-$2 once broken check fib-retracement levels https://www.tradingview.com/chart/JUSH/eqq2Ds4f-JUSH-Weekly-Holdings/
0 · Reply
AaronX
AaronX Dec. 16 at 5:46 PM
$MSOS Weekly momentum has picked up tremendously off the recent new. Good to see the cannabis sector is finally getting the love it deserves!! Its just a matter of time 🚀 $TCNNF $CURLF $TSNDF $JUSHF https://www.tradingview.com/chart/MSOS/Ho3F12HL-MSOS-Pure-US-Cannabis-ETF-Weekly/
0 · Reply
mvesk
mvesk Dec. 13 at 4:11 AM
$JUSHF That was it. In at ,37 waiting for 2 again
0 · Reply